Class III

Drug Recall: Cetirizine Hydrochloride Tablets USP 10 mg, 500 Tablets bottles, Manufactured by: Unique Pharmaceuticals Labs, (A Div. of J.B. Chemicals & Pharmaceuticals, Ltd.), Mumbai 400 030, India. Distributed by

JB Chemicals and Pharmaceuticals Ltd · September 12, 2025

Reason for Recall

Tablet/Capsules Imprinted with Wrong ID

Product Description

Cetirizine Hydrochloride Tablets USP 10 mg, 500 Tablets bottles, Manufactured by: Unique Pharmaceuticals Labs, (A Div. of J.B. Chemicals & Pharmaceuticals, Ltd.), Mumbai 400 030, India. Distributed by: Rising Pharma Holdings, Inc., East Brunswick, NJ 08816, NDC 16571-402-50

Distribution

U.S. Nationwide

States Affected

NATIONWIDE

Quantity Affected

13,440 bottles

Source: FDA (openFDA Drug Enforcement)

Recall number: D-0033-2026

Status: ongoing

SafeCheck provides drug interaction information from FDA-approved product labeling (openFDA). This is for informational purposes only and is not medical advice. Always consult your healthcare provider before making medication decisions.